Accessibility Menu
ICU Medical logo

ICU Medical(NASDAQ) ICUI

Current Price$153.26
Market Cap$3.93BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1992)+3,314%
5 Year-21%
1 Year+25%
1 Month+16%
ICU Medical last closing stock price
MetricPriceDate
Last closeUSD 157.442026-07-22
ICU Medical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.33%USD 157.962026-07-15
1 month+15.65%USD 136.142026-06-22
3 month+26.41%USD 124.552026-04-23
Year to date+10.35%USD 142.672025-12-31
1 year+24.71%USD 126.242025-07-22
3 year-10.72%USD 176.352023-07-21
5 year-20.82%USD 198.842021-07-23
Since inception+3,314.36%USD 4.611992-03-31

ICU Medical Financials at a Glance

Market Cap

$3.93BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$2.16B

Net Income (TTM)

$46.34M

EPS (TTM)

$1.85

P/E Ratio

85.02

Dividend

$0.00

Beta (Volatility)

1.01 (Average)

Price

$153.26

Volume

10,185

Open

$155.06

Previous Close

$153.26

Daily Range

$152.78 - $157.38

52-Week Range

$107.00 - $162.85

Estimated Earnings Date

Aug 6, 2026

ICUI: Motley Fool Moneyball Superscore

53

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ICU Medical

ICU Medical makes tools that deliver medicine to hospital patients. These products help nurses and doctors give fluids safely. The company also builds systems to monitor heart and lung health.

Vital Tools for Hospital Care

  • Consumables: Intravenous (IV) sets, needlefree connectors, and tubes used to deliver fluids directly into the bloodstream.
  • Infusion Systems: Large volume pumps and safety software designed to control medication doses at the bedside.
  • Vital Care: Respiratory, anesthesia, and patient monitoring devices used in critical care settings.
  • IV Solutions: Fluids and salts provided through a commercial relationship with a joint venture partner.

Expanding the Portfolio

  • Integrated the Smiths Medical business following its acquisition in 2022 to increase its global product range.
  • Sold 60% of the IV Solutions business to OPF in May 2025.
  • Formed the Otsuka ICU Medical LLC joint venture to manage the remaining interest in the IV Solutions business.
  • Entered an agreement in March 2026 to sell specific assets from a smaller portion of the business.

Precision and Global Reach

ICU Medical sells products worldwide using its own sales teams and independent distributors. Its smart pump technology connects to hospital records to help prevent medication errors in high-pressure environments.

The Latest Financial Results

  • Total revenues reached $530.2 million in Q1 2026, down 12.3% from Q1 2025.
  • Net income turned positive at $30.1 million in Q1 2026, improved from a $15.5 million loss in Q1 2025.
  • Operating income reached $13.6 million in Q1 2026, up 5.4% from the same period in 2025.
  • Net cash from operating activities was $38.9 million in Q1 2026, down 24.2% from Q1 2025.
  • Research and development costs were $21.3 million in Q1 2026, down from $23.3 million in Q1 2025.

Bottom Line

ICU Medical has transitioned from a component manufacturer to a provider of integrated infusion systems. Its recent moves to form joint ventures and divest assets show a focus on core high-technology medical devices.

AI Generated • May 23, 2026

Industry

Healthcare Equipment and Supplies

Employees

13,000

CEO

Vivek Jain

Headquarters

San Clemente, CA 92673, US

ICUI Financials

Key Financial Metrics (TTM)

Gross Margin

36.36%

Operating Margin

3.72%

Net Income Margin

2.15%

Return on Equity

2.19%

Return on Capital

3.04%

Return on Assets

1.15%

Earnings Yield

1.18%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.93BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

24.99M

Volume

10.19K

Avg. Volume

296.81K

Financials (TTM)

Gross Profit

$784.17M

Operating Income

$80.22M

EBITDA

$262.71M

Operating Cash Flow

$167.43M

Capital Expenditure

-$87.03M

Free Cash Flow

$80.40M

Cash & ST Invst.

$288.33M

Total Debt

$1.34B

ICU Medical Performance Analysis

ICU Medical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 2,276,168,00072.9%
20232023-12-31USD 2,258,830,000-0.8%
20242024-12-31USD 2,379,065,0005.3%
20252025-12-31USD 2,230,025,000-6.3%
ICU Medical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-9.2%
Q32025-09-30-2.2%
Q42025-12-310.6%
Q12026-03-31-1.8%
ICU Medical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -3.11N/A
20232023-12-31USD -1.23-60.4%
20242024-12-31USD -4.83292.0%
20252025-12-31USD 0.03N/A
ICU Medical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30327.0%
Q32025-09-30-109.8%
Q42025-12-31-357.1%
Q12026-03-31287.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$530.37M

-12.3%

Gross Profit

$173.10M

-17.6%

Gross Margin

32.64%

N/A

Market Cap

$3.93BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$302.69K

N/A

Employees

13,000

N/A

Net Income

$30.13M

+294.7%

EBITDA

$28.95M

-54.6%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$288.33M

-0.5%

Total Debt

$1.34B

-16.2%

Accounts Receivable

$201.08M

-1.8%

Inventory

$605.59M

+2.6%

Long Term Debt

$1.31B

-15.1%

Short Term Debt

$34.19M

-44.2%

Return on Assets

1.15%

N/A

Return on Invested Capital

2.29%

N/A

Free Cash Flow

$27.61M

-24.8%

Operating Cash Flow

$38.91M

-24.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LIVNLivaNova PLC
$78.61+0.43%
HAEHaemonetics Corporation
$77.40-0.81%
ARQTArcutis Biotherapeutics, Inc.
$27.33-2.04%
IRONDisc Medicine, Inc.
$75.86+2.07%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.76-0.29%
AALAmerican Airlines Group
$13.56-0.08%
TAT&T
$22.96-0.00%
TQQQProShares Trust - ProShares UltraPro Qqq
$66.30-0.06%

Questions About ICUI

What is the current price of ICU Medical?

ICU Medical is trading at $153.26 per share.

What is the 52-week range for ICU Medical?

Over the past 52 weeks, ICU Medical has traded between $107.00 and $162.85.

How much debt does ICU Medical have?

As of the most recent reporting period, ICU Medical reported total debt of $1.34B.

How much cash does ICU Medical have on hand?

ICU Medical reported $288.33M in cash and cash equivalents in its most recent financial results.

What is ICU Medical’s dividend yield?

ICU Medical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.